health - "develop"

NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, today announced data from its Pilot Efficacy Study of its Oral Spray formulation of sumatriptan (Sumatriptan OS) compared to sumatriptan tablets, marketed as Imitrex®/Imigran®, the leading triptan indicated for the treatment of migraine headaches.

A new framework for pre-registration nursing education is to be developed with a view to ensuring that the new nurse of tomorrow is able to work safely and effectively to meet the needs of the people in their care as the delivery of healthcare services continues to change. At today's Nursing and Midwifery Council (NMC) meeting, Council members agreed to a set of principles (

Stroke experts at The Methodist Hospital in Houston are the first to develop and use 13 quality measures - previously considered too complicated to apply by hospitals - for a national comprehensive stroke center model, as recommended by the Brain Attack Coalition (BAC) and appearing in the Sept. 5 issue of Critical Pathways in Cardiology.

Digirad Corporation (Nasdaq: DRAD), a leading provider of medical diagnostic imaging systems and services to physicians' offices, hospitals and imaging centers, announced the initial clinical trial of a new imaging system incorporating new proprietary technology to correct attenuation, or image distortion, an inherent issue in cardiac SPECT imaging.